Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the area of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering hope for more curative treatment opti